175 related articles for article (PubMed ID: 20351695)
21. Heat-stable antigen (CD24) as ligand for mouse P-selectin.
Sammar M; Aigner S; Hubbe M; Schirrmacher V; Schachner M; Vestweber D; Altevogt P
Int Immunol; 1994 Jul; 6(7):1027-36. PubMed ID: 7524641
[TBL] [Abstract][Full Text] [Related]
22. Heat-stable antigen (mouse CD24) in the brain: dual but distinct interaction with P-selectin and L1.
Sammar M; Aigner S; Altevogt P
Biochim Biophys Acta; 1997 Feb; 1337(2):287-94. PubMed ID: 9048906
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel single chain fragment variable antibody targeting CD24-expressing cancer cells.
Eyvazi S; Kazemi B; Bandehpour M; Dastmalchi S
Immunol Lett; 2017 Oct; 190():240-246. PubMed ID: 28866120
[TBL] [Abstract][Full Text] [Related]
24. The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells.
Friederichs J; Zeller Y; Hafezi-Moghadam A; Gröne HJ; Ley K; Altevogt P
Cancer Res; 2000 Dec; 60(23):6714-22. PubMed ID: 11118057
[TBL] [Abstract][Full Text] [Related]
25. Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.
Li X; Tian W; Jiang Z; Song Y; Leng X; Yu J
Cancer Immunol Immunother; 2024 Jan; 73(2):31. PubMed ID: 38279998
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody BA-1 to the human B lymphocyte marker CD24 recognizes a sialic acid (N-acetylneuraminic acid) dependent epitope in multi-valent display on peptide.
Mehmet H; Larkin M; Tang PW; Lebien TW; Feizi T
Clin Exp Immunol; 1990 Sep; 81(3):489-95. PubMed ID: 1697799
[TBL] [Abstract][Full Text] [Related]
27. The CD24 protein inducible expression system is an ideal tool to explore the potential of CD24 as an oncogene and a target for immunotherapy in vitro and in vivo.
Shapira S; Kazanov D; Weisblatt S; Starr A; Arber N; Kraus S
J Biol Chem; 2011 Nov; 286(47):40548-55. PubMed ID: 21976680
[TBL] [Abstract][Full Text] [Related]
28. Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.
O'Boyle KP; Markowitz AL; Khorshidi M; Lalezari P; Longenecker BM; Lloyd KO; Welt S; Wright KE
Hybridoma; 1996 Dec; 15(6):401-8. PubMed ID: 8985750
[TBL] [Abstract][Full Text] [Related]
29. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.
Seko A; Ohkura T; Ideo H; Yamashita K
Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669
[TBL] [Abstract][Full Text] [Related]
30. Distribution of CD44/CD24 positive cells in ductal invasive carcinoma of breast of different grade and molecular subtype.
Gudadze M; Kankava K; Mariamidze A; Mosidze T; Burkadze G
Georgian Med News; 2013 Sep; (222):50-7. PubMed ID: 24099815
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel dendritic cell surface antigen defined by carbohydrate specific CD24 antibody cross-reactivity.
Williams LA; McLellan AD; Summers KL; Sorg RV; Fearnley DB; Hart DN
Immunology; 1996 Sep; 89(1):120-5. PubMed ID: 8911149
[TBL] [Abstract][Full Text] [Related]
32. CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.
Jing X; Cui X; Liang H; Hao C; Yang Z; Li X; Yang X; Han C
Cell Physiol Biochem; 2018; 48(1):111-119. PubMed ID: 30001552
[TBL] [Abstract][Full Text] [Related]
33. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies VIB-E3, IB5 and HB9 to the leucocyte/epithelial antigen CD24 resemble BA-1 in recognizing sialic acid-dependent epitope(s). Evidence that VIB-E3 recognizes NeuAc alpha 2-6GalNAc and NeuAc alpha 2-6Gal sequences.
Larkin M; Knapp W; Stoll MS; Mehmet H; Feizi T
Clin Exp Immunol; 1991 Sep; 85(3):536-41. PubMed ID: 1716543
[TBL] [Abstract][Full Text] [Related]
35. Cytoplasmic expression of a CD24-related epitope in human PHA activated normal T lymphocytes.
Salamone MC; Achino B; Fainboim L
Immunol Lett; 1992; 34(2):109-13. PubMed ID: 1283152
[TBL] [Abstract][Full Text] [Related]
36. The biological roles of CD24 in ovarian cancer: old story, but new tales.
Gu Y; Zhou G; Tang X; Shen F; Ding J; Hua K
Front Immunol; 2023; 14():1183285. PubMed ID: 37359556
[TBL] [Abstract][Full Text] [Related]
37. Cluster of differentiation 24 expression is an independent prognostic factor of adverse outcome in cervical carcinoma.
Huang LW; Lee CC
Int J Gynecol Cancer; 2013 Feb; 23(2):325-30. PubMed ID: 23318912
[TBL] [Abstract][Full Text] [Related]
38. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A
Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861
[TBL] [Abstract][Full Text] [Related]
39. Native and sialic acid masked Lewis(a) antigen reactivity in medullary thyroid carcinoma. Distinct tumour-associated and prognostic relevant antigens.
Vierbuchen M; Schröder S; Larena A; Uhlenbruck G; Fischer R
Virchows Arch; 1994; 424(2):205-11. PubMed ID: 8180782
[TBL] [Abstract][Full Text] [Related]
40. Are CD44
Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
